DFAT
Dimensional U.S. Targeted Value ETF
DFAT is an active, tax-managed fund that seeks to provide long-term capital appreciation from a portfolio of US mid and small-cap value stocks.
US
EQUITY
Active
MANAGEMENT STYLE
$ 31.2 B
ASSETS UNDER MGMT
28 bp
EXPENSES
Fund Basics
| Inception date | Jun 14, 2021 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| CONTRA ADVERUM BIOTECH COMMON STOCK NPV | 1.4 % |
| REGAL BELOIT CORP | 1.0 % |
| OVINTIV INC | 0.9 % |
| APA CORP. | 0.8 % |
| BALL CORP | 0.7 % |
| CNH INDUSTRIAL NV | 0.7 % |
| JM SMUCKER CO/THE | 0.7 % |
| HF SINCLAIR CORPORATION | 0.6 % |
| TOLL BROTHERS INC | 0.6 % |
| ANTERO RESOURCES CORP | 0.6 % |
Constituent Breakdown
| Number of holdings | 1237 |
| Herfindahl-Hirschman Index | 26 |
| Wgt avg mkt cap (mns) | $6,798 |
| Large cap (>$10bn) | 24.7% |
| Mid cap ($2-10bn) | 59.2% |
| Small cap (<$2bn) | 14.4% |
| Developed mkts. | 98.9% |
| Emerging mkts. | 0.2% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 91.8 % |
 |
BERMUDA | 2.6 % |
 |
BRITAIN | 1.6 % |
 |
IRELAND | 0.7 % |
 |
PUERTO RICO | 0.7 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 11.6% | 14.1% | 9.3% | 13.3% | 8.4% | -- | -- | 7.3% |
| Dividend Yield | 1.2% | 1.7% | 1.7% | 1.7% | 1.7% | -- | -- | 1.6% |
| Total Returns | 12.8% | 15.8% | 11.0% | 15.0% | 10.0% | -- | -- | 8.9% | Ann. Volatility | 14.2% | 14.9% | 19.5% | 19.7% | 21.0% | -- | -- | 21.0% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.75 | 42% |
| MSCI EAFE | 0.59 | 40% |
| MSCI Emg Mkts | 0.27 | 22% |
Liquidity Measures
| Avg. volume (000) | 292 |
| ADV traded (mns) | $20 |
| Turnover | 0.1% |
| Avg. Bid/Ask (% of price) | 0.05% |
Technical Indicators
| 30d moving avg. (EMA) | $69.01 |
| Relative strength (RSI) | 54 |
| MACD/Signal | 0.47/0.19 |
| Bollinger Bands (Upper/Lower) | $70.90/$66.39 |
| Short interest (% of AUM) | 0.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. DFAT |
Expenses vs. DFAT |
ALTAR Score™ vs. DFAT |
|---|---|---|---|---|
| DFSV | Dimensional US Small Cap Value ETF | 65.7% | +5 bp | +0.2% |
| DFAS | Dimensional U.S. Small Cap ETF | 48.3% | -2 bp | -3.1% |
| ISCV | iShares Morningstar Small Cap Value ETF | 48.1% | -22 bp | -1.1% |
| VBR | Vanguard Small Cap Value ETF | 41.3% | -23 bp | -0.9% |
| AVSC | Avantis U.S Small Cap Equity ETF | 40.8% | -3 bp | -3.2% |
| EZM | WisdomTree U.S. MidCap Fund | 39.2% | +10 bp | -0.6% |
| VTWV | Vanguard Russell 2000 Value ETF | 37.4% | -22 bp | -3.3% |
| IWN | iShares Russell 2000 Value ETF | 37.4% | -4 bp | -3.5% |
| FSMD | Fidelity Small-Mid Multifactor ETF | 36.5% | -13 bp | -1.5% |
| FNX | First Trust Mid Cap Core AlphaDEX Fund | 36.2% | +34 bp | -1.8% |
Risk and Returns: DFAT vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
9.1%
ALTAR SCORE™
95th
PERCENTILE
SPECULATIVE
ETFRC RATING
There are 1,388 funds in the US Equity category with an average
ALTAR Score™ of 5.7% and a standard deviation
of 2.1%. DFAT's ALTAR Score™ is approximately 1.7 standard
deviations above the category average. This places DFAT in the 95th percentile
among funds in the category.
Sell-Side Consensus
$83.62
PRICE TARGET
+21.3%
UPSIDE